Butchko Julia G.'s Form 4 filing
Immunovant, Inc. (IMVT) · filed Jul 29, 2022
- Accession no.
- 0001764013-22-000078
- Filed
- Jul 29, 2022
- Trade date
- Jul 27, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.18K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Butchko Julia G.CIK 0001796290 | Officer (Chief Dev. & Tech. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2022 | Common Stock | SSaleDisposed | −510 | $4.27 | −$2,177.7 | 281,104 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.